| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |